Notice of Results

RNS Number : 9494S
OptiBiotix Health PLC
23 March 2016
 

23 March 2016

OptiBiotix Health Plc

 

Notice of Results

Analyst Briefing

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its preliminary results for the year ended 30 November 2015 on Thursday 14 April 2016.

 

A briefing for analysts will take place in the Gresham room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW at 9.30am on Thursday 14 April 2016.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.

 

 

 For further information:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive



Cairn Financial Advisers LLP

Tel: 020 7148 7900

Liam Murray / Avi Robinson




Hybridan LLP (Joint Broker)

Claire Louise Noyce

                                           Tel: 020 3764 2341



Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams




Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFFRVTIFFIR
UK 100

Latest directors dealings